Intrinsic Value of S&P & Nasdaq Contact Us

CareTrust REIT, Inc. CTRE NYSE

NYSE • Real Estate • REIT - Healthcare Facilities • US • USD

SharesGrow Score
79/100
5/7 Pass
SharesGrow Intrinsic Value
$17.53
-55.4%
Analyst Price Target
$42.50
+8%

CareTrust REIT, Inc. (CTRE) is a REIT - Healthcare Facilities company in the Real Estate sector, currently trading at $39.35. It has a SharesGrow Score of 79/100, indicating a strong investment profile with 5 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of CTRE = $17.53 (-55.4% from the current price, the stock appears overvalued). Analyst consensus target is CTRE = $43 (+8% upside).

Valuation: CTRE trades at a trailing Price-to-Earnings (P/E) of 26.9 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 3.6.

Financials: revenue is $477M, +43.2%/yr average growth. Net income is $321M, growing at +104.8%/yr. Net profit margin is 67.3% (strong). Gross margin is 59.1% (-35.9 pp trend).

Balance sheet: total debt is $894M against $4.0B equity (Debt-to-Equity (D/E) ratio 0.22, conservative). Current ratio is 1.54 (strong liquidity). Debt-to-assets is 17.4%. Total assets: $5.1B.

Analyst outlook: 14 / 19 analysts rate CTRE as buy (74%) — strong consensus.

SharesGrow 7-Criteria breakdown: Value 41/100 (Partial), Growth 100/100 (Pass), Past 100/100 (Pass), Health 83/100 (Pass), Moat 55/100 (Partial), Future 73/100 (Pass), Income 100/100 (Pass).

$42.50
▲ 8.01% Upside
Average Price Target
Based on 19 Wall Street analysts offering 12-month price targets for CareTrust REIT, Inc., the average price target is $42.50, with a high forecast of $44.00, and a low forecast of $40.00.
Highest Price Target
$44.00
Average Price Target
$42.50
Lowest Price Target
$40.00

CTRE SharesGrow Score Overview

79/100
SharesGrow Score
Strong investment profile
View full scorecard →
VALUE 41/100
Valuation — P/E, PEG, Forward PEG
GROWTH 100/100
Financials — average growth
PAST 100/100
strong — trend
HEALTH 83/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 55/100
Gross margin is + market cap
FUTURE 73/100
Analyst outlook — as buy
INCOME 100/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — CTRE

~
VALUE Partial
41/100
CTRE trades at a trailing Price-to-Earnings (P/E) of 26.9 (S&P 500 average ~25). Forward PEG 3.6 — overvalued. Trailing PEG 1.73. Analyst consensus target is $43, implying +9.3% from the current price $39. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
GROWTH Pass
100/100
CTRE: +43.2%/yr revenue is, +104.8%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
PAST Pass
100/100
CTRE: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
HEALTH Pass
83/100
Balance sheet CTRE: Debt-to-Equity (D/E) ratio 0.22 (conservative), Current ratio is 1.54 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
55/100
CTRE: Gross margin is 59.1% (-35.9 pp trend), $9B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 55/100. ≥ 70 = Pass.
View details →
FUTURE Pass
73/100
Analyst outlook: 14 / 19 analysts rate CTRE as buy (74%). Analyst consensus target is $43 (+9.3% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
INCOME Pass
100/100
CTRE: Net profit margin is 67.3%. strong (≥30%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range25.82-41.72
Volume2.26M
Avg Volume (30D)2.75M
Market Cap$8.78B
Beta (1Y)0.79
Dividend Yield$1.3950
Share Statistics
EPS (TTM)1.57
Shares Outstanding$203.64M
IPO Date2014-05-29
Employees21
CEODavid Sedgwick
Financial Highlights & Ratios
Revenue (TTM)$476.59M
Gross Profit$281.79M
EBITDA$462.08M
Net Income$320.54M
Operating Income$320.14M
Total Cash$198.04M
Total Debt$894.22M
Net Debt$696.18M
Total Assets$5.15B
Price / Earnings (P/E)25.1
Price / Sales (P/S)18.43
Analyst Forecast
1Y Price Target$43.00
Target High$44.00
Target Low$40.00
Upside+9.3%
Rating ConsensusBuy
Analysts Covering19
Buy 74% Hold 21% Sell 5%
Price Target Summary
Company Info
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS14174T1079

Price Chart

CTRE
CareTrust REIT, Inc.  ·  NYSE
Real Estate • REIT - Healthcare Facilities
25.82 52WK RANGE 41.72
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message